CIK 0001655759
- Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472566120
- Phone
- +1 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,475
- in 1 filing, $1K under 10b5-1 plans
Net −$1,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-08-07 | Cassidy Sean A Chief Financial Officer | Exercise or conversion | +6,250 | $16.00 | $100K | 169,115 |
| 2019-08-07 | Cassidy Sean A Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −1,980 | 0 | ||
| 2019-08-07 | Cassidy Sean A Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −2,212 | 12,948 | ||
| 2019-08-07 | Cassidy Sean A Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −2,058 | 3,142 | ||
| 2019-07-29 | Cassidy Sean A Chief Financial Officer | Sale | −10,777 | $26.13 | $282K | 164,033 |
| 2019-07-29 | Cassidy Sean A Chief Financial Officer | Sale | −1,108 | $27.04 | $30K | 162,925 |
| 2019-07-29 | Cassidy Sean A Chief Financial Officer | Sale | −60 | $28.03 | $2K | 162,865 |
| 2019-07-29 | Peck Ronald Chief Medical Officer | Grant or award · Restricted Stock Units | +16,041 | 16,041 | ||
| 2019-07-29 | Peck Ronald Chief Medical Officer | Grant or award · Stock Option (right to buy) | +72,184 | 72,184 | ||
| 2019-07-24 | Norwalk Leslie V Director | Grant or award · Stock Option (right to buy) | +25,846 | 25,846 | ||
| 2019-07-11 | Houston John G President and CEO | Grant or award · Stock Option (right to buy) | +13,360 | 13,360 | ||
| 2019-06-28 | 5AM VENTURES III, L.P. 10% owner | Sale | −350,955 | $22.02 | $7.7M | 3,537,261 |
| 2019-06-28 | 5AM VENTURES III, L.P. 10% owner | Sale | −9,045 | $22.02 | $199K | 91,162 |
| 2019-06-27 | 5AM VENTURES III, L.P. 10% owner | Sale | −438,694 | $21.75 | $9.5M | 3,888,216 |
| 2019-06-27 | 5AM VENTURES III, L.P. 10% owner | Sale | −11,306 | $21.75 | $246K | 100,207 |
| 2019-06-10 | Canaan IX L.P. 10% owner | Other disposition | −500,000 | 4,489,554 | ||
| 2019-06-07 | 5AM VENTURES III, L.P. 10% owner | Sale | −185,226 | $19.65 | $3.6M | 4,326,910 |
| 2019-06-07 | 5AM VENTURES III, L.P. 10% owner | Sale | −4,774 | $19.65 | $94K | 111,513 |
| 2019-05-23 | Kennedy Edward Moore Jr. Director | Grant or award · Stock Option (right to buy) | +12,923 | 12,923 | ||
| 2019-05-23 | SHANNON TIMOTHY M Director | Grant or award · Stock Option (right to buy) | +12,923 | 12,923 |
Page 26 of 32 · 628 trades